153 related articles for article (PubMed ID: 11702113)
1. Feasibility of a short acquisition protocol for whole-body positron emission tomography with fluorine-18 fluorodeoxyglucose.
Paul AK; Tatsumi M; Fujino K; Hashikawa K; Nishimura T
Eur J Nucl Med; 2001 Nov; 28(11):1697-701. PubMed ID: 11702113
[TBL] [Abstract][Full Text] [Related]
2. A lesion detection observer study comparing 2-dimensional versus fully 3-dimensional whole-body PET imaging protocols.
Lartizien C; Kinahan PE; Comtat C
J Nucl Med; 2004 Apr; 45(4):714-23. PubMed ID: 15073270
[TBL] [Abstract][Full Text] [Related]
3. Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability.
Halpern BS; Dahlbom M; Quon A; Schiepers C; Waldherr C; Silverman DH; Ratib O; Czernin J
J Nucl Med; 2004 May; 45(5):797-801. PubMed ID: 15136629
[TBL] [Abstract][Full Text] [Related]
4. Whole-body positron emission tomography in clinical oncology: comparison between attenuation-corrected and uncorrected images.
Bengel FM; Ziegler SI; Avril N; Weber W; Laubenbacher C; Schwaiger M
Eur J Nucl Med; 1997 Sep; 24(9):1091-8. PubMed ID: 9283100
[TBL] [Abstract][Full Text] [Related]
5. Optimal dose of 18F-FDG required for whole-body PET using an LSO PET camera.
Everaert H; Vanhove C; Lahoutte T; Muylle K; Caveliers V; Bossuyt A; Franken PR
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1615-9. PubMed ID: 14504831
[TBL] [Abstract][Full Text] [Related]
6. Head and neck cancer: dedicated FDG PET/CT protocol for detection--phantom and initial clinical studies.
Yamamoto Y; Wong TZ; Turkington TG; Hawk TC; Coleman RE
Radiology; 2007 Jul; 244(1):263-72. PubMed ID: 17495174
[TBL] [Abstract][Full Text] [Related]
7. Attenuation correction in whole-body FDG oncological studies: the role of statistical reconstruction.
Lonneux M; Borbath I; Bol A; Coppens A; Sibomana M; Bausart R; Defrise M; Pauwels S; Michel C
Eur J Nucl Med; 1999 Jun; 26(6):591-8. PubMed ID: 10369944
[TBL] [Abstract][Full Text] [Related]
8. Value of iterative reconstruction, attenuation correction, and image fusion in the interpretation of FDG PET images with an integrated dual-head coincidence camera and X-ray-based attenuation maps.
Delbeke D; Martin WH; Patton JA; Sandler MP
Radiology; 2001 Jan; 218(1):163-71. PubMed ID: 11152796
[TBL] [Abstract][Full Text] [Related]
9. Optimization of a shorter variable-acquisition time for legs to achieve true whole-body PET/CT images.
Umeda T; Miwa K; Murata T; Miyaji N; Wagatsuma K; Motegi K; Terauchi T; Koizumi M
Australas Phys Eng Sci Med; 2017 Dec; 40(4):861-868. PubMed ID: 29098601
[TBL] [Abstract][Full Text] [Related]
10. Integrated whole-body PET/MR hybrid imaging: clinical experience.
Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
[TBL] [Abstract][Full Text] [Related]
11. Comparison of dedicated breast positron emission tomography and whole-body positron emission tomography/computed tomography images: a common phantom study.
Satoh Y; Motosugi U; Imai M; Onishi H
Ann Nucl Med; 2020 Feb; 34(2):119-127. PubMed ID: 31768819
[TBL] [Abstract][Full Text] [Related]
12. Optimizing positron emission tomography image acquisition protocols in integrated positron emission tomography/magnetic resonance imaging.
Hartung-Knemeyer V; Beiderwellen KJ; Buchbender C; Kuehl H; Lauenstein TC; Bockisch A; Poeppel TD
Invest Radiol; 2013 May; 48(5):290-4. PubMed ID: 23399811
[TBL] [Abstract][Full Text] [Related]
13. FDG PET and dual-head gamma camera positron coincidence detection imaging of suspected malignancies and brain disorders.
Delbeke D; Patton JA; Martin WH; Sandler MP
J Nucl Med; 1999 Jan; 40(1):110-7. PubMed ID: 9935066
[TBL] [Abstract][Full Text] [Related]
14. Optimizing imaging protocols for overweight and obese patients: a lutetium orthosilicate PET/CT study.
Halpern BS; Dahlbom M; Auerbach MA; Schiepers C; Fueger BJ; Weber WA; Silverman DH; Ratib O; Czernin J
J Nucl Med; 2005 Apr; 46(4):603-7. PubMed ID: 15809482
[TBL] [Abstract][Full Text] [Related]
15. Advantage of delayed whole-body FDG-PET imaging for tumour detection.
Kubota K; Itoh M; Ozaki K; Ono S; Tashiro M; Yamaguchi K; Akaizawa T; Yamada K; Fukuda H
Eur J Nucl Med; 2001 Jun; 28(6):696-703. PubMed ID: 11440029
[TBL] [Abstract][Full Text] [Related]
16. F-18-FDG positron imaging in oncological patients: gamma camera coincidence detection versus dedicated PET.
Zimny M; Kaiser HJ; Cremerius U; Sabri O; Schreckenberger M; Reinartz P; Büll U
Nuklearmedizin; 1999; 38(4):108-14. PubMed ID: 10392375
[TBL] [Abstract][Full Text] [Related]
17. [Cancer detection with whole-body FDG PET images without attenuation correction].
Yasuda S; Ide M; Takagi S; Shohtsu A; Mitomi T; Kobayashi S; Suzuki Y
Kaku Igaku; 1996 Apr; 33(4):367-73. PubMed ID: 8683875
[TBL] [Abstract][Full Text] [Related]
18. Simulated Reduced-Count Whole-Body FDG PET: Evaluation in Children and Young Adults Imaged on a Digital PET Scanner.
Alves VPV; Brady S; Ata NA; Li Y; MacLean J; Zhang B; Sharp SE; Trout AT
AJR Am J Roentgenol; 2022 Dec; 219(6):952-961. PubMed ID: 35731102
[No Abstract] [Full Text] [Related]
19. Impact of acquisition geometry, image processing, and patient size on lesion detection in whole-body 18F-FDG PET.
El Fakhri G; Santos PA; Badawi RD; Holdsworth CH; Van Den Abbeele AD; Kijewski MF
J Nucl Med; 2007 Dec; 48(12):1951-60. PubMed ID: 18006613
[TBL] [Abstract][Full Text] [Related]
20. The effect of acquisition time on visual and semi-quantitative analysis of F-18 FDG-PET studies in patients with head and neck cancer.
Goethals I; D'Asseler Y; Dobbeleir A; Deblaere K; Ham H
Nucl Med Commun; 2010 Mar; 31(3):227-31. PubMed ID: 20023593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
